These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine. Lauria F; Benfenati D; Raspadori D; Rondelli D; Zinzani PL; Tura S Leuk Lymphoma; 1993 Nov; 11(5-6):399-404. PubMed ID: 7907247 [TBL] [Abstract][Full Text] [Related]
3. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications. Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389 [TBL] [Abstract][Full Text] [Related]
4. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland. Robak T; Błasińska-Morawiec M; Błoński J; Hellmann A; Hałaburda K; Konopka L; Kotlarek-Haus S; Potoczek S; Hansz J; Dmoszyńska A; Urasiński I; Zdziarska B; Dwilewicz-Trojaczek J; Hołowiecki J; Skotnicki AB Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312 [TBL] [Abstract][Full Text] [Related]
5. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey. Lauria F; Rondelli D; Zinzani PL; Bocchia M; Marotta G; Salvucci M; Raspadori D; Ventura MA; Birtolo S; Forconi F; Tura S Leukemia; 1997 May; 11(5):629-32. PubMed ID: 9180283 [TBL] [Abstract][Full Text] [Related]
6. 2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia. Robak T; Błasińska-Morawiec M; Krykowski E; Hansz J; Komarnicki M; Kazimierczak M; Konopka L; Maj S; Hellmann A; Zaucha JM; Urasiński L; Zdziarska B; Kotlarek-Haus S; Usnarska-Zubkiewicz L; Kuratowska Z; Dwilewicz-Trojaczek J; Hołowiecki J; Krawczyk-Kulis M; Grieb P Leuk Lymphoma; 1996 Jun; 22(1-2):107-11. PubMed ID: 8724536 [TBL] [Abstract][Full Text] [Related]
7. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine. Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616 [TBL] [Abstract][Full Text] [Related]
8. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment. Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine. Jehn U; Bartl R; Dietzfelbinger H; Vehling-Kaiser U; Wolf-Hornung B; Hill W; Heinemann V Ann Hematol; 1999 Mar; 78(3):139-44. PubMed ID: 10211756 [TBL] [Abstract][Full Text] [Related]
10. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine. Seymour JF; Estey EH; Keating MJ; Kurzrock R Leukemia; 1995 May; 9(5):929-32. PubMed ID: 7769859 [TBL] [Abstract][Full Text] [Related]
11. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Tallman MS; Hakimian D; Variakojis D; Koslow D; Sisney GA; Rademaker AW; Rose E; Kaul K Blood; 1992 Nov; 80(9):2203-9. PubMed ID: 1358262 [TBL] [Abstract][Full Text] [Related]
12. Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. Hoffman MA; Janson D; Rose E; Rai KR J Clin Oncol; 1997 Mar; 15(3):1138-42. PubMed ID: 9060556 [TBL] [Abstract][Full Text] [Related]
13. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine). Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. Zinzani PL; Magagnoli M; Bendandi M; Tani M; Stefoni V; Cellini C; Poggi S; Piccioli M; Pileri S; Tura S Haematologica; 2000 Sep; 85(9):922-5. PubMed ID: 10980629 [TBL] [Abstract][Full Text] [Related]